Dean Y Li insider trades

Open-market stock purchases and sales by Dean Y Li, Director at Recursion Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 26, 2021.

Recent trades

DateStockTradeValue
Oct 1, 2026RXRX Recursion Pharmaceuticals, IncBought (not open market)—
Jul 1, 2026RXRX Recursion Pharmaceuticals, IncBought (not open market)—
Jun 17, 2026RXRX Recursion Pharmaceuticals, IncBought (not open market)—
May 5, 2026MRK Merck & Co, IncBought (not open market)—
May 5, 2026MRK Merck & Co, IncBought (not open market)—
Apr 29, 2026MRK Merck & Co, IncSold (not open market)$256K
Apr 29, 2026MRK Merck & Co, IncBought (not open market)—
Apr 1, 2026RXRX Recursion Pharmaceuticals, IncBought (not open market)—
Feb 10, 2026MRK Merck & Co, IncSold$1.2M
Feb 4, 2026MRK Merck & Co, IncSold$1.8M
Feb 4, 2026MRK Merck & Co, IncBought (not open market)—
Jan 26, 2026MRK Merck & Co, IncBought (not open market)$2.2M
Jan 2, 2026RXRX Recursion Pharmaceuticals, IncBought (not open market)—

Companies traded

  • RXRX Recursion Pharmaceuticals, Inc: 8 sales, last Oct 1, 2026
  • MRK Merck & Co, Inc: 3 sales, last May 5, 2026

Get free alerts when Dean Y Li files a new trade →